Live Breaking News & Updates on Bard Peripheral Vascular

Stay updated with breaking news from Bard peripheral vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysis Appears to Debunk Paclitaxel-Coated Device Risk in PAD

VOYAGER-PAD finds no excess mortality or amputation risk with paclitaxel-coated devices When a 2018 meta-analysis of 28 trials reported "a significant relationship" between exposure to paclitaxel via a drug-eluting stent used to treat peripheral artery disease (PAD) and excess mortality, the FDA responded by first issuing a warning letter, followed by a second letter urging ....

United States , Bad Krozingen , Baden Wüberg , Thomas Zeller , Peggy Peck , Connien Hess , Valentin Fuster , Industry Consortium Medtronic , Division Of Cardiology , Boston Scientific , University Heart Center Freiburg , Gore Associates , University Of Jena , University Of Colorado School Medicine , Journal Of The American College Cardiology , Clinical Research , Boston Scientific Corp , Janssen Pharmaceuticals , Department Of Medicine , American College , Mount Sinai Heart , Physician In Chief Mount Sinai Hospital , Colorado School , Swedish Drug Elution Trial , Peripheral Arterial Disease , Pan Industry Consortium ,